Access cutting-edge kidney cancer treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access kidney cancer specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney cancer treatment provided free
This phase III trial compares the effect of adding tivozanib to standard therapy pembrolizumab versus pembrolizumab alone for the treatment of patients with high-risk renal cell carcinoma (RCC). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Tivozanib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal prot
Sponsor: Alliance for Clinical Trials in Oncology
Check if you qualify for this kidney cancer clinical trial in Tucson, AZ
If you're searching for kidney cancer treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.